nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Rigors—Vemurafenib—skin cancer	0.0196	0.0196	CcSEcCtD
Ceftibuten—Dehydration—Vismodegib—skin cancer	0.0175	0.0175	CcSEcCtD
Ceftibuten—Nephropathy toxic—Bleomycin—skin cancer	0.0169	0.0169	CcSEcCtD
Ceftibuten—Rigors—Imiquimod—skin cancer	0.0167	0.0167	CcSEcCtD
Ceftibuten—Drug fever—Docetaxel—skin cancer	0.0163	0.0163	CcSEcCtD
Ceftibuten—Vaginal inflammation—Imiquimod—skin cancer	0.0137	0.0137	CcSEcCtD
Ceftibuten—Vaginal infection—Imiquimod—skin cancer	0.0129	0.0129	CcSEcCtD
Ceftibuten—Aphasia—Temozolomide—skin cancer	0.0126	0.0126	CcSEcCtD
Ceftibuten—Digestion impaired—Temozolomide—skin cancer	0.0122	0.0122	CcSEcCtD
Ceftibuten—Dysgeusia—Vismodegib—skin cancer	0.0111	0.0111	CcSEcCtD
Ceftibuten—Nasal congestion—Imiquimod—skin cancer	0.0109	0.0109	CcSEcCtD
Ceftibuten—Cholestasis—Temozolomide—skin cancer	0.0108	0.0108	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.0105	0.0105	CcSEcCtD
Ceftibuten—Rigors—Temozolomide—skin cancer	0.01	0.01	CcSEcCtD
Ceftibuten—Irritability—Imiquimod—skin cancer	0.00946	0.00946	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00888	0.00888	CcSEcCtD
Ceftibuten—Aplastic anaemia—Dactinomycin—skin cancer	0.0085	0.0085	CcSEcCtD
Ceftibuten—Vaginal inflammation—Temozolomide—skin cancer	0.00818	0.00818	CcSEcCtD
Ceftibuten—Dyspepsia—Vismodegib—skin cancer	0.00814	0.00814	CcSEcCtD
Ceftibuten—Pancytopenia—Imiquimod—skin cancer	0.00814	0.00814	CcSEcCtD
Ceftibuten—Decreased appetite—Vismodegib—skin cancer	0.00804	0.00804	CcSEcCtD
Ceftibuten—Dysuria—Imiquimod—skin cancer	0.00801	0.00801	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Vismodegib—skin cancer	0.00798	0.00798	CcSEcCtD
Ceftibuten—Fatigue—Vismodegib—skin cancer	0.00797	0.00797	CcSEcCtD
Ceftibuten—Constipation—Vismodegib—skin cancer	0.00791	0.00791	CcSEcCtD
Ceftibuten—Candida infection—Temozolomide—skin cancer	0.00781	0.00781	CcSEcCtD
Ceftibuten—Vaginal infection—Temozolomide—skin cancer	0.00773	0.00773	CcSEcCtD
Ceftibuten—Aplastic anaemia—Temozolomide—skin cancer	0.00768	0.00768	CcSEcCtD
Ceftibuten—Erythema multiforme—Vemurafenib—skin cancer	0.0076	0.0076	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00757	0.00757	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Vismodegib—skin cancer	0.00756	0.00756	CcSEcCtD
Ceftibuten—Abdominal pain—Vismodegib—skin cancer	0.00731	0.00731	CcSEcCtD
Ceftibuten—Chills—Vemurafenib—skin cancer	0.00722	0.00722	CcSEcCtD
Ceftibuten—Haemoglobin—Imiquimod—skin cancer	0.00689	0.00689	CcSEcCtD
Ceftibuten—Haemorrhage—Imiquimod—skin cancer	0.00686	0.00686	CcSEcCtD
Ceftibuten—Dysgeusia—Vemurafenib—skin cancer	0.00686	0.00686	CcSEcCtD
Ceftibuten—Rigors—Docetaxel—skin cancer	0.00667	0.00667	CcSEcCtD
Ceftibuten—Asthenia—Vismodegib—skin cancer	0.00663	0.00663	CcSEcCtD
Ceftibuten—Pruritus—Vismodegib—skin cancer	0.00654	0.00654	CcSEcCtD
Ceftibuten—Nasal congestion—Temozolomide—skin cancer	0.00652	0.00652	CcSEcCtD
Ceftibuten—Erythema multiforme—Imiquimod—skin cancer	0.00648	0.00648	CcSEcCtD
Ceftibuten—Diarrhoea—Vismodegib—skin cancer	0.00633	0.00633	CcSEcCtD
Ceftibuten—Chills—Imiquimod—skin cancer	0.00615	0.00615	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00591	0.00591	CcSEcCtD
Ceftibuten—Vomiting—Vismodegib—skin cancer	0.00588	0.00588	CcSEcCtD
Ceftibuten—Rash—Vismodegib—skin cancer	0.00583	0.00583	CcSEcCtD
Ceftibuten—Dermatitis—Vismodegib—skin cancer	0.00583	0.00583	CcSEcCtD
Ceftibuten—Pancytopenia—Bleomycin—skin cancer	0.00578	0.00578	CcSEcCtD
Ceftibuten—Anaphylactic shock—Vemurafenib—skin cancer	0.00571	0.00571	CcSEcCtD
Ceftibuten—Dehydration—Temozolomide—skin cancer	0.00552	0.00552	CcSEcCtD
Ceftibuten—Nausea—Vismodegib—skin cancer	0.00549	0.00549	CcSEcCtD
Ceftibuten—Agitation—Imiquimod—skin cancer	0.00549	0.00549	CcSEcCtD
Ceftibuten—Pancytopenia—Dactinomycin—skin cancer	0.00539	0.00539	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00535	0.00535	CcSEcCtD
Ceftibuten—Neutropenia—Dactinomycin—skin cancer	0.00531	0.00531	CcSEcCtD
Ceftibuten—Irritability—Fluorouracil—skin cancer	0.00522	0.00522	CcSEcCtD
Ceftibuten—Candida infection—Docetaxel—skin cancer	0.0052	0.0052	CcSEcCtD
Ceftibuten—Haematuria—Bleomycin—skin cancer	0.00517	0.00517	CcSEcCtD
Ceftibuten—Convulsion—Imiquimod—skin cancer	0.00517	0.00517	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00502	0.00502	CcSEcCtD
Ceftibuten—Dry mouth—Imiquimod—skin cancer	0.00497	0.00497	CcSEcCtD
Ceftibuten—Decreased appetite—Vemurafenib—skin cancer	0.00497	0.00497	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00493	0.00493	CcSEcCtD
Ceftibuten—Fatigue—Vemurafenib—skin cancer	0.00493	0.00493	CcSEcCtD
Ceftibuten—Haemoglobin—Bleomycin—skin cancer	0.0049	0.0049	CcSEcCtD
Ceftibuten—Constipation—Vemurafenib—skin cancer	0.00489	0.00489	CcSEcCtD
Ceftibuten—Pancytopenia—Temozolomide—skin cancer	0.00488	0.00488	CcSEcCtD
Ceftibuten—Haemorrhage—Bleomycin—skin cancer	0.00487	0.00487	CcSEcCtD
Ceftibuten—Dysuria—Temozolomide—skin cancer	0.0048	0.0048	CcSEcCtD
Ceftibuten—Neutropenia—Temozolomide—skin cancer	0.0048	0.0048	CcSEcCtD
Ceftibuten—Agranulocytosis—Dactinomycin—skin cancer	0.00472	0.00472	CcSEcCtD
Ceftibuten—Anorexia—Imiquimod—skin cancer	0.00464	0.00464	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00454	0.00454	CcSEcCtD
Ceftibuten—Body temperature increased—Vemurafenib—skin cancer	0.00452	0.00452	CcSEcCtD
Ceftibuten—Pancytopenia—Fluorouracil—skin cancer	0.00449	0.00449	CcSEcCtD
Ceftibuten—Insomnia—Imiquimod—skin cancer	0.00441	0.00441	CcSEcCtD
Ceftibuten—Paraesthesia—Imiquimod—skin cancer	0.00438	0.00438	CcSEcCtD
Ceftibuten—Chills—Bleomycin—skin cancer	0.00437	0.00437	CcSEcCtD
Ceftibuten—Dyspnoea—Imiquimod—skin cancer	0.00434	0.00434	CcSEcCtD
Ceftibuten—Somnolence—Imiquimod—skin cancer	0.00433	0.00433	CcSEcCtD
Ceftibuten—Erythema multiforme—Dactinomycin—skin cancer	0.0043	0.0043	CcSEcCtD
Ceftibuten—Dyspepsia—Imiquimod—skin cancer	0.00429	0.00429	CcSEcCtD
Ceftibuten—Decreased appetite—Imiquimod—skin cancer	0.00424	0.00424	CcSEcCtD
Ceftibuten—Hypersensitivity—Vemurafenib—skin cancer	0.00421	0.00421	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Imiquimod—skin cancer	0.00421	0.00421	CcSEcCtD
Ceftibuten—Fatigue—Imiquimod—skin cancer	0.0042	0.0042	CcSEcCtD
Ceftibuten—Renal impairment—Docetaxel—skin cancer	0.00415	0.00415	CcSEcCtD
Ceftibuten—Haemoglobin—Temozolomide—skin cancer	0.00413	0.00413	CcSEcCtD
Ceftibuten—Haemorrhage—Temozolomide—skin cancer	0.00411	0.00411	CcSEcCtD
Ceftibuten—Asthenia—Vemurafenib—skin cancer	0.0041	0.0041	CcSEcCtD
Ceftibuten—Chills—Dactinomycin—skin cancer	0.00408	0.00408	CcSEcCtD
Ceftibuten—Pruritus—Vemurafenib—skin cancer	0.00404	0.00404	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Imiquimod—skin cancer	0.00398	0.00398	CcSEcCtD
Ceftibuten—Agranulocytosis—Fluorouracil—skin cancer	0.00394	0.00394	CcSEcCtD
Ceftibuten—Diarrhoea—Vemurafenib—skin cancer	0.00391	0.00391	CcSEcCtD
Ceftibuten—Erythema multiforme—Temozolomide—skin cancer	0.00389	0.00389	CcSEcCtD
Ceftibuten—Urticaria—Imiquimod—skin cancer	0.00387	0.00387	CcSEcCtD
Ceftibuten—Body temperature increased—Imiquimod—skin cancer	0.00385	0.00385	CcSEcCtD
Ceftibuten—Abdominal pain—Imiquimod—skin cancer	0.00385	0.00385	CcSEcCtD
Ceftibuten—Haemoglobin—Fluorouracil—skin cancer	0.00381	0.00381	CcSEcCtD
Ceftibuten—Haemorrhage—Fluorouracil—skin cancer	0.00379	0.00379	CcSEcCtD
Ceftibuten—Dizziness—Vemurafenib—skin cancer	0.00378	0.00378	CcSEcCtD
Ceftibuten—Chills—Temozolomide—skin cancer	0.00369	0.00369	CcSEcCtD
Ceftibuten—Dehydration—Docetaxel—skin cancer	0.00367	0.00367	CcSEcCtD
Ceftibuten—Vomiting—Vemurafenib—skin cancer	0.00363	0.00363	CcSEcCtD
Ceftibuten—Rash—Vemurafenib—skin cancer	0.0036	0.0036	CcSEcCtD
Ceftibuten—Dermatitis—Vemurafenib—skin cancer	0.0036	0.0036	CcSEcCtD
Ceftibuten—Hypersensitivity—Imiquimod—skin cancer	0.00359	0.00359	CcSEcCtD
Ceftibuten—Headache—Vemurafenib—skin cancer	0.00358	0.00358	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00356	0.00356	CcSEcCtD
Ceftibuten—Dysgeusia—Temozolomide—skin cancer	0.0035	0.0035	CcSEcCtD
Ceftibuten—Asthenia—Imiquimod—skin cancer	0.0035	0.0035	CcSEcCtD
Ceftibuten—Anaphylactic shock—Bleomycin—skin cancer	0.00346	0.00346	CcSEcCtD
Ceftibuten—Pruritus—Imiquimod—skin cancer	0.00345	0.00345	CcSEcCtD
Ceftibuten—Nausea—Vemurafenib—skin cancer	0.00339	0.00339	CcSEcCtD
Ceftibuten—Diarrhoea—Imiquimod—skin cancer	0.00333	0.00333	CcSEcCtD
Ceftibuten—Anorexia—Bleomycin—skin cancer	0.0033	0.0033	CcSEcCtD
Ceftibuten—Agitation—Temozolomide—skin cancer	0.00329	0.00329	CcSEcCtD
Ceftibuten—Pancytopenia—Docetaxel—skin cancer	0.00324	0.00324	CcSEcCtD
Ceftibuten—Dizziness—Imiquimod—skin cancer	0.00322	0.00322	CcSEcCtD
Ceftibuten—Neutropenia—Docetaxel—skin cancer	0.00319	0.00319	CcSEcCtD
Ceftibuten—Paraesthesia—Bleomycin—skin cancer	0.00311	0.00311	CcSEcCtD
Ceftibuten—Convulsion—Temozolomide—skin cancer	0.0031	0.0031	CcSEcCtD
Ceftibuten—Vomiting—Imiquimod—skin cancer	0.0031	0.0031	CcSEcCtD
Ceftibuten—Dyspnoea—Bleomycin—skin cancer	0.00309	0.00309	CcSEcCtD
Ceftibuten—Anorexia—Dactinomycin—skin cancer	0.00308	0.00308	CcSEcCtD
Ceftibuten—Rash—Imiquimod—skin cancer	0.00307	0.00307	CcSEcCtD
Ceftibuten—Dermatitis—Imiquimod—skin cancer	0.00307	0.00307	CcSEcCtD
Ceftibuten—Headache—Imiquimod—skin cancer	0.00305	0.00305	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00302	0.00302	CcSEcCtD
Ceftibuten—Decreased appetite—Bleomycin—skin cancer	0.00301	0.00301	CcSEcCtD
Ceftibuten—Renal failure—Docetaxel—skin cancer	0.00299	0.00299	CcSEcCtD
Ceftibuten—Dry mouth—Temozolomide—skin cancer	0.00298	0.00298	CcSEcCtD
Ceftibuten—Jaundice—Docetaxel—skin cancer	0.00297	0.00297	CcSEcCtD
Ceftibuten—Anaphylactic shock—Temozolomide—skin cancer	0.00292	0.00292	CcSEcCtD
Ceftibuten—Nausea—Imiquimod—skin cancer	0.00289	0.00289	CcSEcCtD
Ceftibuten—Convulsion—Fluorouracil—skin cancer	0.00286	0.00286	CcSEcCtD
Ceftibuten—Agranulocytosis—Docetaxel—skin cancer	0.00284	0.00284	CcSEcCtD
Ceftibuten—Decreased appetite—Dactinomycin—skin cancer	0.00281	0.00281	CcSEcCtD
Ceftibuten—Fatigue—Dactinomycin—skin cancer	0.00278	0.00278	CcSEcCtD
Ceftibuten—Anorexia—Temozolomide—skin cancer	0.00278	0.00278	CcSEcCtD
Ceftibuten—Urticaria—Bleomycin—skin cancer	0.00275	0.00275	CcSEcCtD
Ceftibuten—Haemoglobin—Docetaxel—skin cancer	0.00275	0.00275	CcSEcCtD
Ceftibuten—Body temperature increased—Bleomycin—skin cancer	0.00274	0.00274	CcSEcCtD
Ceftibuten—Haemorrhage—Docetaxel—skin cancer	0.00273	0.00273	CcSEcCtD
Ceftibuten—Anaphylactic shock—Fluorouracil—skin cancer	0.00269	0.00269	CcSEcCtD
Ceftibuten—Insomnia—Temozolomide—skin cancer	0.00264	0.00264	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Dactinomycin—skin cancer	0.00264	0.00264	CcSEcCtD
Ceftibuten—Paraesthesia—Temozolomide—skin cancer	0.00262	0.00262	CcSEcCtD
Ceftibuten—Dyspnoea—Temozolomide—skin cancer	0.0026	0.0026	CcSEcCtD
Ceftibuten—Somnolence—Temozolomide—skin cancer	0.0026	0.0026	CcSEcCtD
Ceftibuten—Erythema multiforme—Docetaxel—skin cancer	0.00258	0.00258	CcSEcCtD
Ceftibuten—Dyspepsia—Temozolomide—skin cancer	0.00257	0.00257	CcSEcCtD
Ceftibuten—Anorexia—Fluorouracil—skin cancer	0.00256	0.00256	CcSEcCtD
Ceftibuten—Abdominal pain—Dactinomycin—skin cancer	0.00255	0.00255	CcSEcCtD
Ceftibuten—Body temperature increased—Dactinomycin—skin cancer	0.00255	0.00255	CcSEcCtD
Ceftibuten—Hypersensitivity—Bleomycin—skin cancer	0.00255	0.00255	CcSEcCtD
Ceftibuten—Decreased appetite—Temozolomide—skin cancer	0.00254	0.00254	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Temozolomide—skin cancer	0.00252	0.00252	CcSEcCtD
Ceftibuten—Fatigue—Temozolomide—skin cancer	0.00252	0.00252	CcSEcCtD
Ceftibuten—Constipation—Temozolomide—skin cancer	0.0025	0.0025	CcSEcCtD
Ceftibuten—Asthenia—Bleomycin—skin cancer	0.00248	0.00248	CcSEcCtD
Ceftibuten—Chills—Docetaxel—skin cancer	0.00245	0.00245	CcSEcCtD
Ceftibuten—Pruritus—Bleomycin—skin cancer	0.00245	0.00245	CcSEcCtD
Ceftibuten—Insomnia—Fluorouracil—skin cancer	0.00243	0.00243	CcSEcCtD
Ceftibuten—Paraesthesia—Fluorouracil—skin cancer	0.00242	0.00242	CcSEcCtD
Ceftibuten—Dyspnoea—Fluorouracil—skin cancer	0.0024	0.0024	CcSEcCtD
Ceftibuten—Somnolence—Fluorouracil—skin cancer	0.00239	0.00239	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Temozolomide—skin cancer	0.00239	0.00239	CcSEcCtD
Ceftibuten—Hypersensitivity—Dactinomycin—skin cancer	0.00238	0.00238	CcSEcCtD
Ceftibuten—Dyspepsia—Fluorouracil—skin cancer	0.00237	0.00237	CcSEcCtD
Ceftibuten—Decreased appetite—Fluorouracil—skin cancer	0.00234	0.00234	CcSEcCtD
Ceftibuten—Dysgeusia—Docetaxel—skin cancer	0.00233	0.00233	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00232	0.00232	CcSEcCtD
Ceftibuten—Urticaria—Temozolomide—skin cancer	0.00232	0.00232	CcSEcCtD
Ceftibuten—Asthenia—Dactinomycin—skin cancer	0.00232	0.00232	CcSEcCtD
Ceftibuten—Abdominal pain—Temozolomide—skin cancer	0.00231	0.00231	CcSEcCtD
Ceftibuten—Body temperature increased—Temozolomide—skin cancer	0.00231	0.00231	CcSEcCtD
Ceftibuten—Diarrhoea—Dactinomycin—skin cancer	0.00221	0.00221	CcSEcCtD
Ceftibuten—Vomiting—Bleomycin—skin cancer	0.0022	0.0022	CcSEcCtD
Ceftibuten—Rash—Bleomycin—skin cancer	0.00218	0.00218	CcSEcCtD
Ceftibuten—Dermatitis—Bleomycin—skin cancer	0.00218	0.00218	CcSEcCtD
Ceftibuten—Hypersensitivity—Temozolomide—skin cancer	0.00215	0.00215	CcSEcCtD
Ceftibuten—Urticaria—Fluorouracil—skin cancer	0.00214	0.00214	CcSEcCtD
Ceftibuten—Body temperature increased—Fluorouracil—skin cancer	0.00213	0.00213	CcSEcCtD
Ceftibuten—Asthenia—Temozolomide—skin cancer	0.00209	0.00209	CcSEcCtD
Ceftibuten—Pruritus—Temozolomide—skin cancer	0.00207	0.00207	CcSEcCtD
Ceftibuten—Convulsion—Docetaxel—skin cancer	0.00206	0.00206	CcSEcCtD
Ceftibuten—Nausea—Bleomycin—skin cancer	0.00206	0.00206	CcSEcCtD
Ceftibuten—Vomiting—Dactinomycin—skin cancer	0.00205	0.00205	CcSEcCtD
Ceftibuten—Rash—Dactinomycin—skin cancer	0.00204	0.00204	CcSEcCtD
Ceftibuten—Diarrhoea—Temozolomide—skin cancer	0.002	0.002	CcSEcCtD
Ceftibuten—Hypersensitivity—Fluorouracil—skin cancer	0.00198	0.00198	CcSEcCtD
Ceftibuten—Dry mouth—Docetaxel—skin cancer	0.00198	0.00198	CcSEcCtD
Ceftibuten—Anaphylactic shock—Docetaxel—skin cancer	0.00194	0.00194	CcSEcCtD
Ceftibuten—Dizziness—Temozolomide—skin cancer	0.00193	0.00193	CcSEcCtD
Ceftibuten—Nausea—Dactinomycin—skin cancer	0.00192	0.00192	CcSEcCtD
Ceftibuten—Pruritus—Fluorouracil—skin cancer	0.0019	0.0019	CcSEcCtD
Ceftibuten—Vomiting—Temozolomide—skin cancer	0.00186	0.00186	CcSEcCtD
Ceftibuten—Anorexia—Docetaxel—skin cancer	0.00185	0.00185	CcSEcCtD
Ceftibuten—Rash—Temozolomide—skin cancer	0.00184	0.00184	CcSEcCtD
Ceftibuten—Diarrhoea—Fluorouracil—skin cancer	0.00184	0.00184	CcSEcCtD
Ceftibuten—Dermatitis—Temozolomide—skin cancer	0.00184	0.00184	CcSEcCtD
Ceftibuten—Headache—Temozolomide—skin cancer	0.00183	0.00183	CcSEcCtD
Ceftibuten—Dizziness—Fluorouracil—skin cancer	0.00178	0.00178	CcSEcCtD
Ceftibuten—Insomnia—Docetaxel—skin cancer	0.00176	0.00176	CcSEcCtD
Ceftibuten—Paraesthesia—Docetaxel—skin cancer	0.00174	0.00174	CcSEcCtD
Ceftibuten—Nausea—Temozolomide—skin cancer	0.00173	0.00173	CcSEcCtD
Ceftibuten—Dyspnoea—Docetaxel—skin cancer	0.00173	0.00173	CcSEcCtD
Ceftibuten—Somnolence—Docetaxel—skin cancer	0.00173	0.00173	CcSEcCtD
Ceftibuten—Vomiting—Fluorouracil—skin cancer	0.00171	0.00171	CcSEcCtD
Ceftibuten—Dyspepsia—Docetaxel—skin cancer	0.00171	0.00171	CcSEcCtD
Ceftibuten—Rash—Fluorouracil—skin cancer	0.0017	0.0017	CcSEcCtD
Ceftibuten—Dermatitis—Fluorouracil—skin cancer	0.00169	0.00169	CcSEcCtD
Ceftibuten—Decreased appetite—Docetaxel—skin cancer	0.00169	0.00169	CcSEcCtD
Ceftibuten—Headache—Fluorouracil—skin cancer	0.00169	0.00169	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Docetaxel—skin cancer	0.00168	0.00168	CcSEcCtD
Ceftibuten—Fatigue—Docetaxel—skin cancer	0.00167	0.00167	CcSEcCtD
Ceftibuten—Constipation—Docetaxel—skin cancer	0.00166	0.00166	CcSEcCtD
Ceftibuten—Nausea—Fluorouracil—skin cancer	0.0016	0.0016	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Docetaxel—skin cancer	0.00159	0.00159	CcSEcCtD
Ceftibuten—Abdominal pain—Docetaxel—skin cancer	0.00153	0.00153	CcSEcCtD
Ceftibuten—Body temperature increased—Docetaxel—skin cancer	0.00153	0.00153	CcSEcCtD
Ceftibuten—Hypersensitivity—Docetaxel—skin cancer	0.00143	0.00143	CcSEcCtD
Ceftibuten—Asthenia—Docetaxel—skin cancer	0.00139	0.00139	CcSEcCtD
Ceftibuten—Pruritus—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Ceftibuten—Diarrhoea—Docetaxel—skin cancer	0.00133	0.00133	CcSEcCtD
Ceftibuten—Dizziness—Docetaxel—skin cancer	0.00128	0.00128	CcSEcCtD
Ceftibuten—Vomiting—Docetaxel—skin cancer	0.00123	0.00123	CcSEcCtD
Ceftibuten—Rash—Docetaxel—skin cancer	0.00122	0.00122	CcSEcCtD
Ceftibuten—Dermatitis—Docetaxel—skin cancer	0.00122	0.00122	CcSEcCtD
Ceftibuten—Headache—Docetaxel—skin cancer	0.00122	0.00122	CcSEcCtD
Ceftibuten—Nausea—Docetaxel—skin cancer	0.00115	0.00115	CcSEcCtD
